Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2453-2456

  Deligezer, Ugur ^a   Akisik, Ebru E ^a   Dalay, Nejat ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b IU Oncology Institute   (Turkey)

Author keywords

Chronic myelogenous leukemia; CML; Melting curve; Polymorphism; XRCC1

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CODON; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 34547824729     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Karakosta A, Golias Ch, Charalabopoulos A, Peschos D, Batistatou A and Charalabopoulos K: Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia. J Exp Clin Cancer Res 24: 505-514, 2005.
2. Hur M, Park JY, Cho HC, Lee KM, Shin HY and Cho HI: Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population. Clin Lab Haematol 28: 154-159, 2006.
3. Schnittger S, Kohl TM, Leopold N, Schoch C, Wichmann HE, Kern W, Lohse P, Hiddemann W, Haferlach T and Spiekermann K: D324N single-nucleotide polymorphism in the FLT3 gene is associated with higher risk of myeloid leukemias. Genes Chromosomes Cancer 45: 332-337, 2006.
4. Hishida A, Terakura S, Emi N, Yamamoto K, Murata M, Nishio K, Sekido Y, Niwa T, Hamajima N and Naoe T: GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pac J Cancer Prev 6: 251-255, 2005.
5. Bergamaschi G, Merante S, Orlandi E, Galli A, Bernasconi P and Cazzola M: TP53 codon 72 polymorphism in patients with chronic myeloid leukemia. Haematologica 89: 868-869, 2004.
6. Ma X, Ruan G, Wang Y, Li Q, Zhu P, Qin YZ, Li JL, Liu YR, Ma D and Zhao H: Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5′ regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res 11: 8592-8599, 2005.
7. Amirzargar AA, Bagheri M, Ghavamzadeh A, Alimoghadam K, Khosravi F, Rezaei N, Moheydin M, Ansaripour B, Moradi B and Nikbin B: Cytokine gene polymorphism in Iranian patients with chronic myelogenous leukaemia. Int J Immunogenet 32: 167-171, 2005.
8. Spitz MR, Wei Q, Dong Q, Amos CI and Wu X: Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-698, 2003.
9. Caldecott KW, Tucker JD, Stanker LH and Thompson LH: Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res 23: 4836-4843, 1995.
10. Vidal AE, Boiteux S, Hickson ID and Radicella JP: XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 20: 6530-6539, 2001.
11. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE and Lindahl T: Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 15: 6662-6670, 1996.
12. Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J and de Murcia G: XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18: 3563-7351, 1998.
13. Lunn RM, Langlois RG, Hsieh LL, Thompson CL and Bell DA: XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59: 2557-2561, 1999.
14. Qu T and Morimoto K: X-ray repair cross-complementing group 1 polymorphisms and cancer risks in Asian populations: a mini review. Cancer Detect Prev 29: 215-220, 2005.
15. Hu Z, Ma H, Chen F, Wei Q and Shen H: XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14: 1810-1818, 2005.
16. Hung RJ, Hall J, Brennan P and Boffetta P: Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162: 925-942, 2005.
17. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N and Das-Gupta E: The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia. Blood 100: 3761-3766, 2002.
18. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual (second ed.). New York, Cold Spring Harbour Laboratory Prev, pp. E3-E4, 1989.
19. Schneider J, Classen V, Philipp M and Helmig S: Rapid analysis of XRCC1 polymorphisms using real-time polymerase chain reaction. Mol Cell Probes 20: 259-262, 2006.
20. Deligezer U and Dalay N: Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients. Exp Mol Med 36: 572-575, 2004.